Literature DB >> 31009791

Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?

Parambir S Dulai1, Siddharth Singh2, Niels Vande Casteele2, Brigid S Boland2, Jesus Rivera-Nieves2, Peter B Ernst2, Lars Eckmann2, Kim E Barrett2, John T Chang2, William J Sandborn2.   

Abstract

Crohn's disease (CD) is an inflammatory bowel disease that can involve any region of the gastrointestinal tract. First described in 1932 as terminal ileitis or regional enteritis, it predominately involves the ileum with or without colonic involvement. Isolated colonic CD was first described in 1960 and since then the phenotypic classification of CD has evolved to stratify patients into isolated ileal, ileocolonic, or isolated colonic involvement. In the current review we evaluate the published literature regarding differences in epidemiology, natural history, pathogenesis, response to therapy, and disease monitoring, when stratified by disease location. Based on the available evidence consideration could be given to a new classification for CD, which splits it into ileum dominant (isolated ileal and ileocolonic) and isolated colonic disease. This may allow for a more optimized approach to clinical care and scientific research for CD.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Colonic; Crohn's Disease; Ileal

Mesh:

Substances:

Year:  2019        PMID: 31009791      PMCID: PMC6885453          DOI: 10.1016/j.cgh.2019.04.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  80 in total

1.  Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

2.  A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.

Authors:  C A Siegel; H Horton; L S Siegel; K D Thompson; T Mackenzie; S K Stewart; P W Rice; J M Stempak; S Dezfoli; T Haritunians; A Levy; M Baek; R Milgrom; P S Dulai; S R Targan; M S Silverberg; M C Dubinsky; D P McGovern
Journal:  Aliment Pharmacol Ther       Date:  2015-11-15       Impact factor: 8.171

3.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease.

Authors:  Johan Dicksved; Jonas Halfvarson; Magnus Rosenquist; Gunnar Järnerot; Curt Tysk; Juha Apajalahti; Lars Engstrand; Janet K Jansson
Journal:  ISME J       Date:  2008-04-10       Impact factor: 10.302

Review 4.  The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases.

Authors:  Carolijn Smids; Carmen S Horjus Talabur Horje; Femke van Wijk; Ellen G van Lochem
Journal:  J Crohns Colitis       Date:  2017-04-01       Impact factor: 9.071

5.  Nod2 is essential for temporal development of intestinal microbial communities.

Authors:  Ateequr Rehman; Christian Sina; Olga Gavrilova; Robert Häsler; Stephan Ott; John F Baines; Stefan Schreiber; Philip Rosenstiel
Journal:  Gut       Date:  2011-03-18       Impact factor: 23.059

6.  Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients.

Authors:  J Li; A L Doty; Y Tang; D Berrie; A Iqbal; S A Tan; M J Clare-Salzler; S M Wallet; S C Glover
Journal:  Clin Exp Immunol       Date:  2017-07-07       Impact factor: 4.330

7.  Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.

Authors:  Aoibhlinn O'Toole; Alaa Alakkari; Denise Keegan; Glen Doherty; Hugh Mulcahy; Diarmuid O'Donoghue
Journal:  Clin Gastroenterol Hepatol       Date:  2011-11-15       Impact factor: 11.382

8.  A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells.

Authors:  Ken Cadwell; John Y Liu; Sarah L Brown; Hiroyuki Miyoshi; Joy Loh; Jochen K Lennerz; Chieko Kishi; Wumesh Kc; Javier A Carrero; Steven Hunt; Christian D Stone; Elizabeth M Brunt; Ramnik J Xavier; Barry P Sleckman; Ellen Li; Noboru Mizushima; Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Nature       Date:  2008-10-05       Impact factor: 49.962

9.  Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.

Authors:  Ronald K Linskens; Rosalie C Mallant-Hent; Z M Anthonie Groothuismink; Liesbeth E Bakker-Jonges; Joop P van de Merwe; Herbert Hooijkaas; B Mary E von Blomberg; Stephan G M Meuwissen
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-09       Impact factor: 2.566

10.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.

Authors:  Martin Baumgart; Belgin Dogan; Mark Rishniw; Gil Weitzman; Brian Bosworth; Rhonda Yantiss; Renato H Orsi; Martin Wiedmann; Patrick McDonough; Sung Guk Kim; Douglas Berg; Ynte Schukken; Ellen Scherl; Kenneth W Simpson
Journal:  ISME J       Date:  2007-07-12       Impact factor: 10.302

View more
  26 in total

Review 1.  Location is important: differentiation between ileal and colonic Crohn's disease.

Authors:  Raja Atreya; Britta Siegmund
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-12       Impact factor: 46.802

2.  A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease.

Authors:  Parambir S Dulai; Vipul Jairath; Neeraj Narula; Emily Wong; Gursimran S Kochhar; Jean-Frederic Colombel; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

3.  From clinical trials to clinical practice: how should we design and evaluate prediction models in the care of IBD?

Authors:  Ryan William Stidham; Andrew Vickers; Karandeep Singh; Akbar K Waljee
Journal:  Gut       Date:  2021-10-22       Impact factor: 31.793

4.  Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease.

Authors:  Parambir S Dulai; Vipul Jairath; Guangyong Zou; Larry W Stitt; Reena Khanna; William J Sandborn; Brian G Feagan; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2021-04-15       Impact factor: 5.325

5.  Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study.

Authors:  Basavaraj Kerur; Eric I Benchimol; Karoline Fiedler; Marisa Stahl; Jeffrey Hyams; Michael Stephens; Ying Lu; Marian Pfefferkorn; Raza Alkhouri; Jennifer Strople; Judith Kelsen; Leah Siebold; Alka Goyal; Joel R Rosh; Neal LeLeiko; Johan Van Limbergen; Anthony L Guerrerio; Ross Maltz; Lina Karam; Eileen Crowley; Anne Griffiths; Melvin B Heyman; Mark Deneau; Keith Benkov; Joshua Noe; Dedrick Mouton; Helen Pappa; Joseph A Galanko; Scott Snapper; Aleixo M Muise; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

6.  Degree of Creeping Fat Assessed by Computed Tomography Enterography is Associated with Intestinal Fibrotic Stricture in Patients with Crohn's Disease: A Potentially Novel Mesenteric Creeping Fat Index.

Authors:  Xue-Hua Li; Shi-Ting Feng; Qing-Hua Cao; J Calvin Coffey; Mark E Baker; Li Huang; Zhuang-Nian Fang; Yun Qiu; Bao-Lan Lu; Zhi-Hui Chen; Yi Li; Dominik Bettenworth; Marietta Iacucci; Can-Hui Sun; Subrata Ghosh; Florian Rieder; Min-Hu Chen; Zi-Ping Li; Ren Mao
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

7.  Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.

Authors:  Xuehua Li; Dong Liang; Jixin Meng; Jie Zhou; Zhao Chen; Siyun Huang; Baolan Lu; Yun Qiu; Mark E Baker; Ziyin Ye; Qinghua Cao; Mingyu Wang; Chenglang Yuan; Zhihui Chen; Shengyu Feng; Yuxuan Zhang; Marietta Iacucci; Subrata Ghosh; Florian Rieder; Canhui Sun; Minhu Chen; Ziping Li; Ren Mao; Bingsheng Huang; Shi-Ting Feng
Journal:  Gastroenterology       Date:  2021-02-17       Impact factor: 33.883

8.  Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn's Disease.

Authors:  Meik Huhn; Martina Herrero San Juan; Balint Melcher; Caroline Dreis; Katrin G Schmidt; Anja Schwiebs; Janet Collins; Josef M Pfeilschifter; Michael Vieth; Jürgen Stein; Heinfried H Radeke
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

9.  Characterization of terminal-ileal and colonic Crohn's disease in treatment-naïve paediatric patients based on transcriptomic profile using logistic regression.

Authors:  Ilkyu Park; Jaeeun Jung; Sugi Lee; Kunhyang Park; Jea-Woon Ryu; Mi-Young Son; Hyun-Soo Cho; Dae-Soo Kim
Journal:  J Transl Med       Date:  2021-06-07       Impact factor: 5.531

Review 10.  Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier.

Authors:  Cambrian Y Liu; Candace M Cham; Eugene B Chang
Journal:  Transl Res       Date:  2021-06-12       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.